Evidence map›Paper›PMID 32461289›Full record

ArticleBMJ open2020

Pneumoperitoneum preconditioning for the prevention of renal function after laparoscopic partial nephrectomy: protocol for a double-blind randomised controlled trial.

Changcheng Zhou, Luwei Xu, Zheng Xu, Yuzheng Ge, Liuhua Zhou, Feng Wang, Jingyu Liu, Gaojian Pan, Tianli Yang, Ruipeng Jia

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03822338 (Pneumoperitoneum Preconditioning for the Prevention of Renal Function After Laparoscopic Partial Nephrectomy), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03822338 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Pneumoperitoneum Preconditioning for the Prevention of Renal Function After Laparoscopic Partial Nephrectomy: a Double-blind Randomized Controlled Trial

TypeinterventionalSponsorNanjing First Hospital, Nanjing Medical UniversityRan2021 to 2023Enrolled86ConditionsIschemia Reperfusion InjuryArmsPneumoperitoneum preconditioning, Sham-Pneumoperitoneum preconditioning
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Changcheng ZhouDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nangjing, Jiangsu, China.
Luwei XuDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nangjing, Jiangsu, China.
Zheng XuDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nangjing, Jiangsu, China.
Yuzheng GeDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nangjing, Jiangsu, China.
Liuhua ZhouDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nangjing, Jiangsu, China.
Feng WangNuclear Medicine Center, Nanjing First Hospital, Nanjing Medical University, Nangjing, Jiangsu, China.
Jingyu LiuDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nangjing, Jiangsu, China.
Gaojian PanDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nangjing, Jiangsu, China.
Tianli YangDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nangjing, Jiangsu, China.
Ruipeng JiaDepartment of Urology, Nanjing First Hospital, Nanjing Medical University, Nangjing, Jiangsu, China urojiarp@njmu.edu.cn.ORCID 0000-0002-5532-5641
Nanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRenal ischaemia reperfusion injury is an inevitable pathophysiology in different clinical situations including laparoscopic partial nephrectomy (LPN), which can obviously decrease the renal function after surgery. Pneumoperitoneum preconditioning (PP) is a promising approach that can yield a protective effect on kidney, which has already been demonstrated in some animal models. The present study is designed to assess whether the PP can yield a clinical renoprotective role after LPN. METHODS AND ANALYSIS: This study is a randomised, prospective, double-blind and parallel controlled clinical trial. Eligible participants will be patients with renal tumours and willing to choose elective LPN. Patients randomised to the treatment arm will receive PP consisted of three cycles of 5 min insufflation and 5 min desufflation before LPN, while the control arm will receive a sham operation. The primary endpoints are glomerular filtration rate and the level of serum cystatin C within 6 months after desufflation. The secondary endpoints are serum creatinine, estimated glomerular filtration rate, alanine transaminase, serum amylase, intestinal fatty acid binding protein, postoperative hospital stay, the incidence of adverse events and mortality in postoperative 6 months. ETHICS AND DISSEMINATION: This study has been approved by the institutional ethics committee of Nanjing First Hospital. The results of this study will be reported faithfully through scientific conferences or published articles. TRIAL REGISTRATION NUMBER: NCT03822338.

Indexed as

InsufflationKidney NeoplasmsLaparoscopyPneumoperitoneumGlomerular Filtration RateHumansNephrectomyProspective StudiesRandomized Controlled Trials as TopicTreatment Outcomelaparoscopic partial nephrectomypneumoperitoneum preconditioningprotocolrandomised controlled trial

Identifiers

PMID32461289
PMCPMC7259839
OpenAlexW3032272117

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.